Scrivens celebrates being a sound NHS choice

Company marks 100th contract milestone after 50 years of campaigning for accessible hearing care on the High Street

18 Feb 2017 by Robina Moss

Nicholas Georgevic and Mark GeorgevicScrivens Opticians & Hearing Care, which campaigns for access to NHS hearing care on the High Street, has won a milestone 100th contract to help people with hearing loss in Stoke-on-Trent.

The company will provide free NHS hearing assessments, hearing aids and all aftercare, including batteries, for adult patients at its Burslem branch on Market Place on behalf of the Stoke-on-Trent Clinical Commissioning Group (CCG).

Stoke-on-Trent is the 100th CCG in England to instruct the company to deliver NHS hearing services in community locations with short waiting times, helping to ease the pressure on busy NHS hospitals.

Scrivens director, Mark Georgevic (pictured right), said: “It is an important achievement for us and one we believe will improve care locally and offer more choice with appointments to suit patients’ lifestyles.”

Mr Georgevic added: “We have provided hearing services for more than 60 years and on behalf of the NHS for 10 years. We have the experience and expertise to help people whose lives are affected by hearing loss and make a real difference to them.”

Highlighting the benefits of hearing care on the High Street, Mr Georgevic concluded: “Scrivens has campaigned for over 50 years to make NHS hearing care as accessible as eye care. Our branches open six days a week and offer flexible appointment times. More than 85% of patients are fitted with their new hearing aids on the day of their first appointment with us.”

Scrivens was awarded its first CCG contract for NHS adult hearing services in October 2012. In the last 12 months, it was signed by a further 24 CCGs to make the company one of the biggest independent providers in the country.

The company provides the NHS Hearing Service within 112 Scrivens branches and in more than 160 medical centres.


Your comments

You must be logged in to join the discussion. Log in

Comments (0)

Report a comment
Close modal